复制和冷的肉毒素A在治疗下水症方面同新鲜一样有效和安全:一项回顾性研究
Alexander Shayesteh1, Antonia Boman1, Emil Hawas1
1Division of Dermatology and Venereology, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
PloS one
|December 4, 2023
概括
冷和解的肉毒素A与新鲜药物一样有效和安全,用于治疗下水症. 这种具有成本效益的方法利用剩余的肉毒毒素,减少浪费并提高诊所的效率.
科学领域:
- 皮肤病学 皮肤病学
- 医学美学 医学美学
- 临床药理学 临床药理学
背景情况:
- 复制和冷的肉毒毒素A经常用于腹水症治疗.
- 研究冷解与新鲜肉毒素A的疗效和安全性对于临床实践至关重要.
研究的目的:
- 为了比较冷解与新鲜abobotulinum毒素 (Dysport®) 和onabotulinum毒素 (Botox®) 的有效性和安全性.
- 评估使用剩余,冷解的肉毒素制剂的临床效用.
主要方法:
- 追溯性研究分析了106名患有下腺透症的患者的治疗前后数据.
- 患者在一个下部接受了新鲜的肉毒素A,并在对侧下部接受了冷解.
- 使用超症疾病严重程度尺度和VAS10分尺度评估有效性;通过副作用监测评估安全性.
主要成果:
- 冰解和新鲜肉毒素A制剂之间的患者报告结果 (超症疾病严重程度表,VAS表) 没有显著差异.
- 多变量回归分析显示,不同制剂或品牌之间的副作用没有显著差异.
- 在冷和解时,abobotulinum毒素和onabotulinum毒素都显示出与新鲜制剂相比的有效性和安全性.
结论:
- 冷解的阿博托毒素和阿博托毒素是用于下液过的新鲜制剂的有效和安全替代品.
- 使用剩余的,冷解的肉毒素制剂,长达6个月,是一个成本和时间有效的策略.
- 这种做法支持高水症治疗中心对肉毒毒素的有效管理.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
684
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
684
Skeletal Muscle Relaxants: Therapeutic Uses
488
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
488
Depolarizing Blockers: Pharmocokinetics
328
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
328
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
431
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
431


